Search Results - "Neoplasm Recurrence, Local/pathology"
-
1
Authors: et al.
Source: N Engl J Med
The New England journal of medicine, vol. 392, no. 16, pp. 1594-1608Subject Terms: Male, Lung Neoplasms, Middle Aged, Article, Monocytes, Dioxygenases, DNA-Binding Proteins, Mice, Observational Studies as Topic, Cell Movement, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, Mutation, Tumor Microenvironment, Animals, Humans, Female, Prospective Studies, Clonal Hematopoiesis, Neoplasm Recurrence, Local, Aged, Carcinoma, Non-Small-Cell Lung/genetics, Carcinoma, Non-Small-Cell Lung/immunology, Carcinoma, Non-Small-Cell Lung/mortality, Carcinoma, Non-Small-Cell Lung/pathology, Clonal Hematopoiesis/genetics, Clonal Hematopoiesis/immunology, Dioxygenases/genetics, DNA-Binding Proteins/genetics, Lung Neoplasms/genetics, Lung Neoplasms/mortality, Lung Neoplasms/pathology, Neoplasm Recurrence, Local/epidemiology, Neoplasm Recurrence, Local/genetics, Neoplasm Recurrence, Local/pathology, Tumor Microenvironment/immunology, Monocytes/immunology, Monocytes/pathology, Cell Movement/genetics, Cell Movement/immunology, Neoplasm Transplantation
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/40267425
https://ora.ox.ac.uk/objects/uuid:e20d5bce-3d87-4ac2-9e89-b887ca4cc72b
https://doi.org/10.1056/nejmoa2413361
https://serval.unil.ch/notice/serval:BIB_435B0ABCF518
https://serval.unil.ch/resource/serval:BIB_435B0ABCF518.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_435B0ABCF5187 -
2
Authors: et al.
Contributors: et al.
Source: Leukemia
Subject Terms: Male, Adult, Immunology, Female [MeSH], 692/308/2779/109, Follow-Up Studies [MeSH], Aged, 80 and over [MeSH], Multiple Myeloma/pathology [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Prospective Studies [MeSH], Middle Aged [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], 692/699/67/1059, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Survival Rate [MeSH], Article, Male [MeSH], Standard of Care [MeSH], Prognosis [MeSH], Multiple Myeloma/mortality [MeSH], Multiple Myeloma/therapy [MeSH], Multiple Myeloma/drug therapy [MeSH], Neoplasm Recurrence, Local/drug therapy [MeSH], article, Drug Resistance, Neoplasm [MeSH], 3211 Oncology and carcinogenesis, Antineoplastic Combined Chemotherapy Protocols, Humans, 1112 Oncology and Carcinogenesis, Prospective Studies, Aged, Aged, 80 and over, OUTCOMES, Science & Technology, 3202 Clinical sciences, 1103 Clinical Sciences, Standard of Care, Hematology, Middle Aged, Prognosis, [SDV] Life Sciences [q-bio], Survival Rate, Oncology, ANTIBODY, Drug Resistance, Neoplasm, Female, Neoplasm Recurrence, Local, 3201 Cardiovascular medicine and haematology, Multiple Myeloma, Life Sciences & Biomedicine, Follow-Up Studies
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/39322709
https://pure.amsterdamumc.nl/en/publications/e814ec41-946c-4b67-a7b5-ce520085f64f
https://doi.org/10.1038/s41375-024-02404-6
https://lirias.kuleuven.be/handle/20.500.12942/768901
https://doi.org/10.1038/s41375-024-02404-6
https://repository.publisso.de/resource/frl:6518595
https://nantes-universite.hal.science/hal-05095631v1
https://nantes-universite.hal.science/hal-05095631v1/document
https://doi.org/10.1038/s41375-024-02404-6 -
3
Authors: et al.
Contributors: et al.
Source: Leukemia
Thieblemont, C, Karimi, Y H, Ghesquieres, H, Cheah, C Y, Clausen, M R, Cunningham, D, Jurczak, W, Do, Y R, Gasiorowski, R, Lewis, D J, Kim, T M, van der Poel, M, Poon, M L, Feldman, T, Linton, K M, Sureda, A, Hutchings, M, Dinh, M H, Kilavuz, N, Soong, D, Mark, T, Sacchi, M, Phillips, T & Lugtenburg, P J 2024, 'Epcoritamab in relapsed/refractory large B-cell lymphoma : 2-year follow-up from the pivotal EPCORE NHL-1 trial', Leukemia, vol. 38, no. 12, pp. 2653-2662. https://doi.org/10.1038/s41375-024-02410-8Subject Terms: Male, Adult, Diffuse/drug therapy, Neoplasm, Residual, Lymphoma, [SDV]Life Sciences [q-bio], Drug Resistance, Antibodies, Bispecific/therapeutic use, Bispecific/therapeutic use, Antibodies, Article, Young Adult, SDG 3 - Good Health and Well-being, Antibodies, Bispecific, Large B-Cell, 80 and over, Humans, Neoplasm Recurrence, Local/pathology, Aged, Aged, 80 and over, Middle Aged, Prognosis, Diffuse, [SDV] Life Sciences [q-bio], Survival Rate, Lymphoma, Large B-Cell, Diffuse/drug therapy, Neoplasm Recurrence, Local, Drug Resistance, Neoplasm, Residual, Neoplasm, Bispecific, Female, Lymphoma, Large B-Cell, Diffuse, Neoplasm Recurrence, Local, Local/pathology, Follow-Up Studies
File Description: Print-Electronic; application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/39322711
https://pure.eur.nl/en/publications/3c54eb4d-faeb-4c85-b4f6-edd2a7cf952f
https://doi.org/10.1038/s41375-024-02410-8
https://cris.maastrichtuniversity.nl/en/publications/22a14d0b-5271-46ca-9989-6de23cbc197e
https://doi.org/10.1038/s41375-024-02410-8
https://portal.findresearcher.sdu.dk/da/publications/dd650af8-de7c-4c5a-9ca9-83dfcfbb3a08
https://doi.org/10.1038/s41375-024-02410-8
https://hal.science/hal-04921791v1
https://doi.org/10.1038/s41375-024-02410-8
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001320152200003&DestLinkType=FullRecord&DestApp=WOS_CPL
https://doi.org/10.1038/s41375-024-02410-8
https://research.manchester.ac.uk/en/publications/6c603c08-0eb4-4e67-96d4-76aa735217ad -
4
Authors: et al.
Source: Leukemia
Subject Terms: 38/77, 692/699/1541/1990/283/1895, Aged [MeSH], Receptors, Chimeric Antigen/immunology [MeSH], 692/308/2779/109/1941, Neoplasm Recurrence, Local/pathology [MeSH], Antigens, CD19/immunology [MeSH], Leukemia, Lymphocytic, Chronic, B-Cell/immunology [MeSH], Male [MeSH], 692/308/575, 13/31, Neoplasm Recurrence, Local/therapy [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Immunotherapy, Adoptive/adverse effects [MeSH], Adult [MeSH], Humans [MeSH], Leukemia, Lymphocytic, Chronic, B-Cell/therapy [MeSH], Middle Aged [MeSH], 13/44, Neoplasm Recurrence, Local/immunology [MeSH], Article, 631/250/251, 692/308/2779/109/1940, Immunotherapy, Adoptive/methods [MeSH], article, Male, Adult, 0301 basic medicine, Cancer Research, 0303 health sciences, Receptors, Chimeric Antigen, Antigens, CD19, Middle Aged, Leukemia, Lymphocytic, Chronic, B-Cell, Immunotherapy, Adoptive, 3. Good health, 03 medical and health sciences, Humans, Female, Genes, Cells and Cell-Based Medicine [Topic 1], Neoplasm Recurrence, Local, Aged, Follow-Up Studies
File Description: application/pdf
-
5
Authors: et al.
Source: Leukemia
Subject Terms: Male, Letter, T-Lymphocytes, Remission Induction, Bone Marrow Cells, Middle Aged, Leukemia, Myeloid, Acute, 38/22, 13/21, Disease Progression [MeSH], 631/67/1990/283/1897, 38/90, Neoplasm Recurrence, Local/pathology [MeSH], 38/91, Male [MeSH], letter, 13/31, Remission Induction [MeSH], Leukemia, Myeloid, Acute/therapy [MeSH], 38/23, Female [MeSH], T-Lymphocytes/immunology [MeSH], Bone Marrow Cells/immunology [MeSH], Bone Marrow Cells/pathology [MeSH], Humans [MeSH], Leukemia, Myeloid, Acute/immunology [MeSH], Leukemia, Myeloid, Acute/diagnosis [MeSH], Middle Aged [MeSH], Recurrence [MeSH], Antibodies, Bispecific/therapeutic use [MeSH], 631/250/251, 631/250/1619/554, Leukemia, Myeloid, Acute/pathology [MeSH], Recurrence, Antibodies, Bispecific, Disease Progression, Humans, Female, Neoplasm Recurrence, Local
-
6
Authors: et al.
Source: Gastric Cancer
Subject Terms: Male, Adult, 0301 basic medicine, LRP1B, 03 medical and health sciences, Stomach Neoplasms, ARID1A, EGC, Pen, Prognosis, Biomarkers, Tumor, Humans, Aged, Aged, 80 and over, 0303 health sciences, Genomics, Middle Aged, DNA-Binding Proteins, Receptors, LDL, Aged, 80 and over [MeSH], Aged [MeSH], Transcription Factors/genetics [MeSH], Stomach Neoplasms/pathology [MeSH], Stomach Neoplasms/surgery [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Stomach Neoplasms/mortality [MeSH], DNA-Binding Proteins/genetics [MeSH], Original Article, Male [MeSH], Neoplasm Recurrence, Local/genetics [MeSH], Stomach Neoplasms/genetics [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Mutation [MeSH], Adult [MeSH], Humans [MeSH], Genomics/methods [MeSH], Middle Aged [MeSH], Microsatellite Instability [MeSH], Receptors, LDL [MeSH], Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], Mutation, Female, Microsatellite Instability, Neoplasm Recurrence, Local, Transcription Factors, Follow-Up Studies
File Description: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document
-
7
Authors: et al.
Source: Ann Surg Oncol
Subject Terms: Male, Gastrointestinal Oncology, Margins of Excision, Adenocarcinoma, Middle Aged, Prognosis, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Gastrectomy/mortality [MeSH], Aged [MeSH], Stomach Neoplasms/pathology [MeSH], Margins of Excision [MeSH], Stomach Neoplasms/surgery [MeSH], Resection margin, Neoplasm Recurrence, Local/pathology [MeSH], Stomach Neoplasms/mortality [MeSH], Neoplasm Recurrence, Local/surgery [MeSH], Male [MeSH], Adenocarcinoma/pathology [MeSH], Surgery, Gastrectomy/methods [MeSH], Gastric cancer, Female [MeSH], Follow-Up Studies [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Survival Rate [MeSH], Prognosis [MeSH], Gastric neoplasm, Margin distance, Adenocarcinoma/mortality [MeSH], Adenocarcinoma/surgery [MeSH], Distal gastrectomy, Stomach Neoplasms, Gastrectomy, Humans, Female, Neoplasm Recurrence, Local, Aged, Follow-Up Studies, Retrospective Studies
-
8
Authors: et al.
Source: J Cancer Res Clin Oncol
Journal of Cancer Research and Clinical Oncology, Vol 151, Iss 5, Pp 1-10 (2025)
Journal of cancer research and clinical oncology, vol. 151, no. 5, pp. 176Subject Terms: Recurrent breast cancer, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Lymph node, Humans, Female, Retrospective Studies, Middle Aged, Breast Neoplasms/pathology, Breast Neoplasms/therapy, Breast Neoplasms/surgery, Neoplasm Recurrence, Local/pathology, Aged, Adult, Lymphatic Metastasis, Lymph Nodes/pathology, Lymph Nodes/surgery, Axilla, Sentinel Lymph Node Biopsy, Prognosis, Sentinel Lymph Node/pathology, Early-stage breast cancer, Locoregional recurrence, RC254-282
File Description: application/pdf
-
9
Authors: et al.
Source: J Neurooncol
Subject Terms: Male, Adult, Aged, 80 and over, Microsurgery, Research, Female [MeSH], Follow-Up Studies [MeSH], Vestibular schwannoma, Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Neuroma, Acoustic/surgery [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Neuroma, Acoustic/radiotherapy [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Radiosurgery/methods [MeSH], Microsurgery/methods [MeSH], Radiosurgery/adverse effects [MeSH], Male [MeSH], Acoustic neuroma, Young Adult [MeSH], Stereotactic radiosurgery, Neuroma, Acoustic/pathology [MeSH], Neuroma, Acoustic, Middle Aged, Radiosurgery, Young Adult, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Humans, Female, Neoplasm Recurrence, Local, Retrospective Studies, Aged, Follow-Up Studies
-
10
Authors: et al.
Source: Leukemia
Subject Terms: Male, Adult, Adolescent, Immunology, Medizin, Graft vs Host Disease, Hematologic Neoplasms/mortality [MeSH], Adolescent [MeSH], Female [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Hematopoietic Stem Cell Transplantation/adverse effects [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], 692/699/1541/1990/283, Recurrence [MeSH], Survival Rate [MeSH], Article, Male [MeSH], 692/308/575, Hematologic Neoplasms/therapy [MeSH], Young Adult [MeSH], Graft vs Host Disease/etiology [MeSH], Hematopoietic Stem Cell Transplantation/methods [MeSH], Transplantation, Homologous [MeSH], article, RELAPSE, RETROSPECTIVE ANALYSIS, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Recurrence, 3211 Oncology and carcinogenesis, UNRELATED DONORS, Humans, Transplantation, Homologous, 1112 Oncology and Carcinogenesis, ACUTE-LEUKEMIA, Aged, OUTCOMES, Science & Technology, 3202 Clinical sciences, Hematopoietic Stem Cell Transplantation, 1103 Clinical Sciences, Hematology, Middle Aged, 3. Good health, Survival Rate, Oncology, Hematologic Neoplasms, Female, Neoplasm Recurrence, Local, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine
File Description: application/pdf; pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38918561
https://hdl.handle.net/20.500.11768/175914
https://doi.org/10.1038/s41375-024-02318-3
https://lirias.kuleuven.be/handle/20.500.12942/745706
https://doi.org/10.1038/s41375-024-02318-3
https://repository.publisso.de/resource/frl:6524100
https://www.ncbi.nlm.nih.gov/pubmed/38918561
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85196827847
https://doi.org/10.1038/s41375-024-02318-3 -
11
Authors: et al.
Source: Breast Cancer Res Treat
Subject Terms: Adult, Aged, 80 and over, 0301 basic medicine, Gene Expression Profiling, Clinical Decision-Making, Breast Neoplasms, Middle Aged, Prognosis, Clinical Trial, Risk Assessment, Clinical Decision-Making [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Breast cancer, Neoplasm Recurrence, Local/pathology [MeSH], Breast Neoplasms/therapy [MeSH], Neoplasm Staging [MeSH], 21-gene assay, Adjuvant treatment, Neoplasm Recurrence, Local/genetics [MeSH], Ki-67 Antigen/metabolism [MeSH], Chemotherapy, Adjuvant/methods [MeSH], Biomarkers, Tumor [MeSH], Risk Assessment/methods [MeSH], Registry, Breast Neoplasms/pathology [MeSH], Female [MeSH], Recurrence Score, Adult [MeSH], Humans [MeSH], Prospective Studies [MeSH], Breast Neoplasms/genetics [MeSH], Breast Neoplasms/drug therapy [MeSH], Breast Neoplasms/metabolism [MeSH], Middle Aged [MeSH], Prognosis [MeSH], Gene Expression Profiling/methods [MeSH], Ki-67, Registries [MeSH], 03 medical and health sciences, Ki-67 Antigen, 0302 clinical medicine, Chemotherapy, Adjuvant, Biomarkers, Tumor, Humans, Female, Prospective Studies, Registries, Neoplasm Recurrence, Local, Aged, Neoplasm Staging
-
12
Authors: et al.
Contributors: et al.
Source: The lancet. Healthy longevity, vol. 5, no. 6, pp. e392-e405
Subject Terms: Male, Aged, 80 and over, Squamous Cell Carcinoma of Head and Neck, Cetuximab, [SDV.CAN]Life Sciences [q-bio]/Cancer, Humans, Aged, Female, Squamous Cell Carcinoma of Head and Neck/drug therapy, Squamous Cell Carcinoma of Head and Neck/pathology, Head and Neck Neoplasms/drug therapy, Head and Neck Neoplasms/pathology, Neoplasm Recurrence, Local/drug therapy, Neoplasm Recurrence, Local/pathology, Fluorouracil/administration & dosage, Fluorouracil/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Carboplatin/administration & dosage, Carboplatin/therapeutic use, Carboplatin/adverse effects, Cetuximab/administration & dosage, Cetuximab/therapeutic use, Cetuximab/adverse effects, Carboplatin, 3. Good health, [SDV.CAN] Life Sciences [q-bio]/Cancer, Head and Neck Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Fluorouracil, Neoplasm Recurrence, Local
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38759667
https://u-picardie.hal.science/hal-04578230v1
https://doi.org/10.1016/s2666-7568(24)00048-5
https://u-picardie.hal.science/hal-04578230v1/document
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_FC7E3ACA49E02
https://serval.unil.ch/notice/serval:BIB_FC7E3ACA49E0
https://serval.unil.ch/resource/serval:BIB_FC7E3ACA49E0.P001/REF.pdf -
13
Authors: et al.
Source: Breast Cancer Res Treat
Subject Terms: Adult, 0301 basic medicine, Receptor, ErbB-2, Research, Breast Neoplasms, Middle Aged, Breast cancer, Prognostic biomarker, Predictive biomarker, EndoPredict, Adjuvant chemotherapy, Risk stratification, Prognosis, Risk Assessment, Disease-Free Survival, ddc, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Receptors, Estrogen, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Female, Prospective Studies, Aged [MeSH], Receptor, ErbB-2/metabolism [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Neoplasm Staging [MeSH], Risk Assessment/methods [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Female [MeSH], Receptors, Estrogen/metabolism [MeSH], Adult [MeSH], Receptors, Progesterone/metabolism [MeSH], Humans [MeSH], Prospective Studies [MeSH], Treatment Outcome [MeSH], Breast Neoplasms/drug therapy [MeSH], Breast Neoplasms/metabolism [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Biomarkers, Tumor/metabolism [MeSH], Disease-Free Survival [MeSH], Prognosis [MeSH], Neoplasm Recurrence, Local, Receptors, Progesterone, Aged, Neoplasm Staging
File Description: application/pdf
-
14
Authors: et al.
Source: Prostate Cancer Prostatic Dis
Shelan, Mohamed; Achard, Vérane; Appiagyei, Felix; Mose, Lucas; Zilli, Thomas; Fankhauser, Christian D; Zamboglou, Constantinos; Mohamad, Osama; Aebersold, Daniel M; Cathomas, Richard (2024). Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases, 27(3), pp. 422-431. Nature 10.1038/s41391-024-00829-9 <http://dx.doi.org/10.1038/s41391-024-00829-9>Subject Terms: Male, Salvage Therapy, Clinical Trials as Topic, Prostatic Neoplasms, 610 Medicine & health, Review Article, 3. Good health, Prostatic Neoplasms, Castration-Resistant, Phenylthiohydantoin, Nitriles, Benzamides, Androgen Receptor Antagonists, Androgen Receptor Antagonists/therapeutic use [MeSH], Prostatic Neoplasms, Castration-Resistant/pathology [MeSH], Humans [MeSH], Prospective Studies [MeSH], Salvage Therapy [MeSH], Prostatic Neoplasms, Castration-Resistant/drug therapy [MeSH], Prostatic Neoplasms/drug therapy [MeSH], Prostatic Neoplasms/pathology [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], 692/699/2768/589/466, Nitriles [MeSH], Male [MeSH], Phenylthiohydantoin/therapeutic use [MeSH], Phenylthiohydantoin/analogs, Clinical Trials as Topic [MeSH], Benzamides [MeSH], review-article, 692/699/2768, Neoplasm Recurrence, Local/drug therapy [MeSH], Humans, Prospective Studies, Neoplasm Recurrence, Local
File Description: application/pdf; pdf
-
15
Authors: et al.
Source: Radiat Oncol
Radiation Oncology, Vol 20, Iss 1, Pp 1-12 (2025)Subject Terms: Male, Adult, PEG tube, R895-920, Salvage therapy, Re-Irradiation, Medical physics. Medical radiology. Nuclear medicine, Biomarkers, Gastrostomy [MeSH], Squamous Cell Carcinoma of Head and Neck/radiotherapy [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Squamous Cell Carcinoma of Head and Neck/pathology [MeSH], Re-Irradiation [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Reirradiation, Male [MeSH], Squamous Cell Carcinoma of Head and Neck/mortality [MeSH], Biomarkers, Tumor [MeSH], Female [MeSH], Recurrent head and neck cancer, Adult [MeSH], Humans [MeSH], Inflammation, Salvage Therapy [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Head and Neck Neoplasms/mortality [MeSH], Survival Rate [MeSH], Head and Neck Neoplasms/radiotherapy [MeSH], Neoplasm Recurrence, Local/radiotherapy [MeSH], Research, Prognosis [MeSH], Radiotherapy Dosage [MeSH], Head and Neck Neoplasms/pathology [MeSH], Biomarkers, Tumor, Humans, RC254-282, Aged, Retrospective Studies, Salvage Therapy, Gastrostomy, Aged, 80 and over, Squamous Cell Carcinoma of Head and Neck, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Radiotherapy Dosage, Middle Aged, Prognosis, Survival Rate, Head and Neck Neoplasms, Female, Neoplasm Recurrence, Local
-
16
Authors: et al.
Source: J Neurooncol
Subject Terms: Male, Adult, Brain Neoplasms, Research, Tumor Suppressor Proteins, Middle Aged, ddc, Re-Irradiation, Cohort Studies, Tertiary Care Centers, 03 medical and health sciences, DNA Repair Enzymes, 0302 clinical medicine, Glioblastoma, Recurrence, Re-irradiation, 2nd surgery, GTR, Gross total resection, Adjuvant radiotherapy, Cohort study, Humans, Female, Radiotherapy, Adjuvant, Neoplasm Recurrence, Local, Tumor Suppressor Proteins/genetics [MeSH], Aged [MeSH], Tertiary Care Centers [MeSH], Brain Neoplasms/surgery [MeSH], DNA Modification Methylases/metabolism [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Cohort Studies [MeSH], Tumor Suppressor Proteins/metabolism [MeSH], Glioblastoma/radiotherapy [MeSH], DNA Repair Enzymes/metabolism [MeSH], Male [MeSH], Brain Neoplasms/mortality [MeSH], Radiotherapy, Adjuvant [MeSH], Female [MeSH], Brain Neoplasms/radiotherapy [MeSH], Adult [MeSH], Glioblastoma/surgery [MeSH], Humans [MeSH], DNA Repair Enzymes/genetics [MeSH], Middle Aged [MeSH], DNA Modification Methylases/genetics [MeSH], Glioblastoma/mortality [MeSH], Re-Irradiation/methods [MeSH], DNA Modification Methylases, Aged
File Description: application/pdf
-
17
Authors: et al.
Source: Acta Oncol
Acta Oncologica, Vol 63, Iss 1 (2024)
Iisager, L, Ahrenfeldt, J, Keller, A K, Nielsen, T K, Fristrup, N & Lyskjær, I 2024, 'KIDNEY-PAGER: analysis of circulating tumor DNA as a biomarker in renal cancer-an observational trial. Study protocol', Acta Oncologica, vol. 63, no. 1, pp. 51-55. https://doi.org/10.2340/1651-226X.2024.25581
Iisager, L, Ahrenfeldt, J, Keller, A K, Nielsen, T K, Fristrup, N & Lyskjær, I 2024, 'KIDNEY-PAGER : analysis of circulating tumor DNA as a biomarker in renal cancer-an observational trial. Study protocol', Acta oncologica (Stockholm, Sweden), vol. 63, pp. 51-55. https://doi.org/10.2340/1651-226X.2024.25581Subject Terms: circulating tumor DNA, Circulating Tumor DNA/genetics, liquid biopsy, Short Report, biomarkers, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, risk stratification, Kidney, Kidney Neoplasms/genetics, Renal cell carcinoma, Kidney Neoplasms, 6. Clean water, Circulating Tumor DNA, 3. Good health, Observational Studies as Topic, translational research, Carcinoma, Renal Cell/genetics, minimal residual disease, Biomarkers, Tumor, Humans, Biomarkers, Tumor/genetics, Neoplasm Recurrence, Local, Neoplasm Recurrence, Local/pathology, Carcinoma, Renal Cell, RC254-282
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38391290
https://doaj.org/article/09ed88d58e504938a238f78cd2525daa
https://vbn.aau.dk/da/publications/8ecdab20-b864-49ab-8ade-0d128c3d2345
http://www.scopus.com/inward/record.url?scp=85185862733&partnerID=8YFLogxK
https://vbn.aau.dk/ws/files/678981098/Iisager_et_al._2024_._KIDNEY-PAGER_-_analysis_of_circulating_tumor_DNA_as_a_biomarker_in_renal_cancer_-_an_observational_trial._Study_protocol.pdf
https://doi.org/10.2340/1651-226X.2024.25581
http://www.scopus.com/inward/record.url?scp=85185862733&partnerID=8YFLogxK
https://pure.au.dk/portal/en/publications/f0de6a07-7e74-4d14-9e24-87ebe221a4ee
https://doi.org/10.2340/1651-226X.2024.25581 -
18
Authors: et al.
Source: J Neurooncol
JOURNAL OF NEURO-ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
Mirian, C, Jensen, L R, Juratli, T A, Maier, A D, Torp, S H, Shih, H A, Morshed, R A, Young, J S, Magill, S T, Bertero, L, Stummer, W, Spille, D C, Brokinkel, B, Oya, S, Miyawaki, S, Saito, N, Proescholdt, M, Kuroi, Y, Gousias, K, Simon, M, Moliterno, J, Prat-Acin, R, Goutagny, S, Prabhu, V C, Tsiang, J T, Wach, J, Güresir, E, Yamamoto, J, Kim, Y Z, Lee, J H, Koshy, M, Perumal, K, Baskaya, M K, Cannon, D M, Shrieve, D C, Suh, C O, Chang, J H, Kamenova, M, Straumann, S, Soleman, J, Eyüpoglu, I Y, Catalan, T, Lui, A, Theodosopoulos, P V, McDermott, M W, Wang, F, Guo, F, Góes, P, de Paiva Neto, M A, Jamshidi, A, Komotar, R, Ivan, M, Luther, E, Souhami, L, Guiot, M C, Csonka, T, Endo, T, Barrett, O C, Jensen, R, Gupta, T, Patel, A J, Klisch, T J, Kim, J W, Maiuri, F, Barresi, V, Tabernero, M D, Skyrman, S, Broechner, A, Bach, M J, Law, I, Scheie, D, Kristensen, B W, Munch, T N, Meling, T, Fugleholm, K, Blanche, P & Mathiesen, T 2024, ' The importance of considering competing risks in recurrence analysis of intracranial meningioma ', Journal of Neuro-Oncology, pp. 503–511 . https://doi.org/10.1007/s11060-024-04572-y
Journal of Neuro-Oncology, vol 166, iss 3Subject Terms: Medical Sciences, Mental and Social Health, Research, Neurosciences, Competing risk, Risk Assessment, 3. Good health, Neoplasm Recurrence, Neurology, Local, Recurrence, Neuro-oncology, Medical Specialties, Medicine and Health Sciences, Meningeal Neoplasms, Humans, Meningeal Neoplasms/pathology [MeSH], Aged [MeSH], Risk Assessment [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Meningioma/pathology [MeSH], Meningioma, Neoplasm Recurrence, Local/epidemiology [MeSH], Neoplasm Recurrence, Local, Aged, Retrospective Studies
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38336917
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=20381
https://curis.ku.dk/ws/files/382972289/s11060_024_04572_y.pdf
https://repository.publisso.de/resource/frl:6507892
https://escholarship.org/content/qt3w6357n5/qt3w6357n5.pdf
https://escholarship.org/uc/item/3w6357n5 -
19
Authors:
Source: Arch Gynecol Obstet
Subject Terms: Female [MeSH], Endometrial Neoplasms/surgery [MeSH], Hysterectomy [MeSH], Humans [MeSH], Radiotherapy, Adjuvant/adverse effects [MeSH], Endometrial cancer, Neoplasm Recurrence, Local/pathology [MeSH], Feasibility Studies [MeSH], Neoplasm Staging [MeSH], Endometrial Neoplasms/pathology [MeSH], Endometrial Neoplasms/radiotherapy [MeSH], Sentinel node detection, Peritoneal mesometrial resection, Cancer field surgery, Lymph Node Excision/adverse effects [MeSH], Gynecologic Oncology, Targeted compartmental lymphadenectomy, Medizin, Humans, Feasibility Studies, Lymph Node Excision, Female, Radiotherapy, Adjuvant, Neoplasm Recurrence, Local, Hysterectomy, Neoplasm Staging, Endometrial Neoplasms, 3. Good health
-
20
Authors: et al.
Source: Annals of oncology, vol. 36, no. 7, pp. 749-761
Subject Terms: Humans, Lymphoma, Large B-Cell, Diffuse/therapy, Lymphoma, Large B-Cell, Diffuse/immunology, Lymphoma, Large B-Cell, Diffuse/pathology, Lymphoma, Large B-Cell, Diffuse/mortality, Male, Female, Middle Aged, Immunotherapy, Adoptive/methods, Receptors, Chimeric Antigen/immunology, Adult, Aged, Neoplasm Recurrence, Local/therapy, Neoplasm Recurrence, Local/immunology, Neoplasm Recurrence, Local/pathology, Remission Induction, Progression-Free Survival, Follow-Up Studies, CD7, CD71, CXCR3, LAG-3, NKG2D, anti-CD19 CAR T cell infusion products
File Description: application/pdf
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text